NCT07775313 Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07759102 Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE1
NCT07647068 Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors Status NOT_YET_RECRUITING Phase PHASE2
NCT07616154 Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease Status RECRUITING Phase PHASE2
NCT07604233 Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07585136 Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders Status NOT_YET_RECRUITING Phase PHASE1
NCT07278856 Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas Status RECRUITING Phase PHASE1
NCT07257419 CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma Status RECRUITING Phase PHASE1
NCT07224100 Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma Status RECRUITING Phase PHASE2
NCT07064018 Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT07059611 Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07052370 TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Status RECRUITING Phase PHASE1
NCT07012044 A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia Status RECRUITING Phase PHASE1
NCT06942039 Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation Status RECRUITING Phase EARLY_PHASE1
NCT06928662 Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse Status RECRUITING Phase PHASE1/PHASE2
NCT06926751 Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors Status RECRUITING Phase PHASE2
NCT06851767 Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT06738368 Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT06709495 Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas Status RECRUITING Phase PHASE1/PHASE2
NCT06325709 Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease Status RECRUITING Phase PHASE1/PHASE2